Safety of ovarian preservation in premenopausal women with endometrial cancer

Journal of Clinical Oncology

Volumn 27, Issue 8, 2009, Pages 1214-1219

  Wright, Jason D ^a   Buck, Adam M ^a   Shah, Monjri ^a   Burke, William M ^a   Schiff, Peter B ^a   Herzog, Thomas J ^a  

^a

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; DEMOGRAPHY; EARLY CANCER; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; KAPLAN MEIER METHOD; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MARRIAGE; OVARIAN PRESERVATION; OVARIECTOMY; OVARY METASTASIS; OVERALL SURVIVAL; PATIENT SAFETY; PREMENOPAUSE; PRIORITY JOURNAL; RACE; STATISTICAL ANALYSIS; UNITED STATES;

ADULT; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; OVARIECTOMY; PROPORTIONAL HAZARDS MODELS;

EID: 62549108209     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.8150     Document Type: Article

References (37)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58:71-96, 2008
2. Lee NK, Cheung MK, Shin JY, et al: Prognostic factors for uterine cancer in reproductive-aged women. Obstet Gynecol 109:655-662, 2007
3. Gitsch G, Hanzal E, Jensen D, et al: Endometrial cancer in premenopausal women 45 years and younger. Obstet Gynecol 85:504-508, 1995
4. Duska LR, Garrett A, Rueda BR, et al: Endometrial cancer in women 40 years old or younger. Gynecol Oncol 83:388-393, 2001
5. Crissman JD, Azoury RS, Barnes AE, et al:Endometrial carcinoma in women 40 years of age or younger. Obstet Gynecol 57:699-704, 1981
6. Evans-Metcalf ER, Brooks SE, Reale FR, etal: Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol 91:349-354, 1998
7. Gallup DG, Stock RJ: Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol 64:417-120, 1984
8. Tran BN, Connell PP, Waggoner S, et al: Characteristics and outcome of endometrial carcinoma patients age 45 years and younger. Am J Clin Oncol 23:476-180, 2000
9. Ramirez PT, Frumovitz M, Bodurka DC, et al: Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: A literature review. Gynecol Oncol 95:133-138, 2004
10. Surveillance, Epidemiology, and End Results Database, SEER*Stat Database: Incidence-SEER 9 Regs Limited-Use, Nov 2006 Sub (1973-2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission. http://.seer. cancer, gov
11. The Surveillance, Epidemiology, and End Results Program: Data Quality. National Cancer Institute, 2007. http://seer.cancer.gov/about/
12. Frey CM, McMillen MM, Cowan CD, et al: Representativeness of the surveillance, epidemiology, and end results program data: Recent trends in cancer mortality rates. J Natl Cancer Inst 84:872-877, 1992
13. The Comprehensive R Archive Network,http ://cra n. r-project.org/
14. Wallace WH, Thomson AB, Saran F, et al: Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 62:738-744, 2005
15. Atsma F, Bartelink ML, Grobbee DE, et al: Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: A meta-analysis. Menopause 13:265-279, 2006
16. Colditz GA, Willett WC, Stampfer MJ, et el: Menopause and the risk of coronary heart disease in women. N Engl J Med 316:1105-1110, 1987
17. Parrish HM, Carr CA, Hall DG, et al: Time interval from castration in premenopausal women to development of excessive coronary atherosclerosis. Am J Obstet Gynecol 99:155-162, 1967
18. Gordon T, Kannel WB, Hjortland MC, et al: Menopause and coronary heart disease: The Fra-mingham Study. Ann Intern Med 89:157-161, 1978
19. Jacobsen BK, Nilssen S, Heuch I, et al: Does age at natural menopause affect mortality from ischemic heart disease? J Clin Epidemiol 50:475-479, 1997
20. Cooper GS, Sandler DP: Age at natural menopause and mortality. Ann Epidemiol 8:229-235,1998
21. Rocca WA, Bower JH, Maraganore DM, et al: Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 69:1074-1083, 2007
22. Cummings SR, Browner WS, Bauer D, et al: Endogenous hormones and the risk of hip and vertebral fractures among older women: Study of Osteoporotic Fractures Research Group. N Engl J Med 339:733-738, 1998
23. Rosenberg L, Hennekens CH, Rosner B, etal: Early menopause and the risk of myocardial infarction. Am J Obstet Gynecol 139:47-51, 1981
24. Parker WH, Broder MS, Liu Z, et al: Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol 106:219-226, 2005
25. Rocca WA, Grossardt BR, de Andrade M, et al: Survival patterns after oophorectomy in premenopausal women: A population-based cohort study. Lancet Oncol 7:821-828, 2006
26. Holinka CF, Hata H, Kuramoto H, et al: Responses to estradiol in a human endometrial adeno carcinoma cell line (Ishikawa). J Steroid Biochem 24:85-89, 1986
27. Farnell YZ, Ing NH: The effects of estradiol and selective estrogen receptor modulators on gene expression and messenger RNA stability in immortalized sheep endometrial stromal cells and human endometrial adenocarcinoma cells. J Steroid Bio- chem Mol Biol 84:453-461, 2003
28. Barakat RR, Bundy BN, Spirtos NM, et al: Randomized double-blind trial of estrogen replace ment therapy versus placebo in stage I or II endometrial cancer: A Gynecologic Oncology Group Study. J Clin Oncol 24:587-592, 2006
29. Creasman WT, Henderson D, Hinshaw W, et al: Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet Gynecol 67: 326-330, 1986
30. Chapman JA, DiSaia PJ, Osann K, et al: Estrogen replacement in surgical stage I and II endometrial cancer survivors. Am J Obstet Gynecol 175: 1195-1200, 1996
31. Lee RB, Burke TW, Park RC: Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol Oncol 36:189-191, 1990
32. 32.Suriano KA, McHale M, McLaren CE, et al: Estrogen replacement therapy in endometrial cancer patients: A matched control study. Obstet Gynecol 97:555-560, 2001
33. Shamshirsaz AA, Withiam-Leitch M, Odunsi K, et al: Young patients with endometrial carcinoma selected for conservative treatment: A need for vigilance for synchronous ovarian carcinomas, case report and literature review. Gynecol Oncol 104:757-760, 2007
34. Lee TS, Jung JY, Kim JW, et al: Feasibility of ovarian preservation in patients with early stage endometrial carcinoma. Gynecol Oncol 104:52-57, 2007
35. Walsh C, Holschneider C, Hoang Y, et al: Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol 106:693-699, 2005
36. Hicks ML, Phillips JL, Parham G, et al: The National Cancer Data Base report on endometrial carcinoma in African-American women. Cancer 83: 2629-2637, 1998
37. Sherman ME, Devesa SS: Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer 98:176-186, 2003